| Titolo |
Pubblicato in |
Anno |
| Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach |
CANCER IMMUNOLOGY, IMMUNOTHERAPY |
2023 |
| The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management |
FRONTIERS IN ONCOLOGY |
2023 |
| The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives |
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY |
2023 |
| Sexual dysfunctions in breast cancer patients: evidence in context |
SEXUAL MEDICINE REVIEWS |
2023 |
| The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets |
FRONTIERS IN ONCOLOGY |
2023 |
| Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study |
FRONTIERS IN ONCOLOGY |
2023 |
| Angiogenic factors as prognostic markers in neuroendocrine neoplasms |
ENDOCRINE |
2022 |
| Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response |
EBIOMEDICINE |
2022 |
| The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study |
CANCER MANAGEMENT AND RESEARCH |
2022 |
| A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma |
CANCERS |
2022 |
| Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art |
CANCERS |
2022 |
| Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma |
JOURNAL OF CLINICAL MEDICINE |
2022 |
| The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy |
FRONTIERS IN IMMUNOLOGY |
2022 |
| Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis |
CANCER MANAGEMENT AND RESEARCH |
2022 |
| The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study |
CANCERS |
2022 |
| Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives |
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2021 |
| Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era |
JOURNAL OF TRANSLATIONAL MEDICINE |
2021 |
| Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice |
FRONTIERS IN ONCOLOGY |
2021 |
| In vivo imaging-based techniques for early diagnosis of oral potentially malignant disorders—systematic review and meta-analysis |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2021 |
| Role of chemotherapy in vulvar cancers: time to rethink standard of care? |
CANCERS |
2021 |
